ARDS provides today’s main critical-care thread. It is a clinical syndrome arising after an acute insult, with bilateral pulmonary opacities, hypoxaemia and oedema not fully explained by cardiac failure or fluid overload. The PaO₂/FiO₂ ratio helps communicate severity, while lung-protective ventilation should use predicted rather than actual body weight. Lower tidal volumes, limitation of plateau pressure and permissive hypercapnia reduce ventilator-associated injury. Early prone positioning can improve survival in severe ARDS even when oxygenation does not visibly improve after the first session.

Management should continue to follow physiology rather than habit. Plateau pressure, driving pressure, PEEP response, gas exchange and right ventricular tolerance all need review. Neuromuscular blockade may provide short-term control of severe dyssynchrony, while rescue pulmonary vasodilators or VV ECMO require selective use. Once shock has resolved, avoidable positive fluid balance should be reduced, with active diuresis considered when haemodynamically safe. Palliative-care involvement can support communication and decision-making without replacing active treatment.

The breast cancer episode brings immunotherapy toxicity into emergency and perioperative care. Pembrolizumab is used with neoadjuvant chemotherapy for stage 2–3 triple negative breast cancer and may be continued after surgery when tolerated. In metastatic disease, PD-L1 expression informs eligibility. New diarrhoea, cough, dyspnoea, severe fatigue, weakness, hypotension or hyponatraemia should raise concern for immune-mediated colitis, pneumonitis, thyroid dysfunction or adrenal insufficiency. These complications may appear months after the last dose, so pre-operative medication review and endocrine screening need enough time for abnormalities to be addressed.

Profound microcytic anaemia provides a second acute diagnostic challenge. A patient with haemoglobin around 30 g/L may appear surprisingly well when blood loss has developed slowly, but physiological compensation does not make the result benign. An extreme value should be repeated promptly and then investigated when confirmed. Microcytosis and blood in stoma output support chronic gastrointestinal blood loss, while assessment of the stoma, wounds and dressings may reveal problems hidden by self-neglect. Consent, decision-specific capacity and reasonable adjustments remain essential, particularly when autism, ADHD or previous healthcare experiences affect communication or examination.

Clinic-facing material spans PMDD, supplements, cholesterol and adult Refsum disease. Severe cyclical mood disturbance should be mapped against menstrual timing, abrupt recovery and symptom-free intervals rather than dismissed as ordinary PMS or labelled automatically as bipolar disorder. Suicidal thoughts require direct assessment. Supplement counselling should define the intended outcome, evidence, measurable benefit and patient-specific risk before products are continued. Premature myocardial infarction or stroke in relatives should prompt consideration of familial hypercholesterolaemia. In adult Refsum disease, tightening dietary restriction alone may worsen control if inadequate energy intake or weight loss is driving phytanic acid mobilisation.

The remaining episodes reinforce safer clinical systems. Generative AI may support paramedic documentation, education and navigation, but fluent output still requires source checking, privacy protection and accountable human oversight. Food and fluid breaks are framed as patient-safety behaviours rather than personal luxuries. Trauma-informed migraine care similarly looks beyond the immediate symptom, recognising how military sexual trauma and ongoing stress may affect headache burden, engagement and healthcare use.